Body-Clock Testing to Mitigate Health Risks of Night Work: A Prospective Cohort Study Protocol on Chronomedicine for Shift Workers

Article information

Chronobiol Med. 2025;7(4):253-258
Publication date (electronic) : 2025 December 31
doi : https://doi.org/10.33069/cim.2025.0051
1Department of Civil Engineering, Amity University, Lucknow, India
2The Military Nursing Service, Indian Army, Lucknow, India
Corresponding author: Devesh Ojha, PhD, Department of Civil Engineering, Amity University, Lucknow, India. Tel: 91-8004180087, E-mail: dojha@lko.amity.edu
Received 2025 August 13; Revised 2025 August 23; Accepted 2025 November 18.

Abstract

Night-shift work is essential to modern industries but disrupts circadian rhythms, increasing risks of cardiometabolic disease, cancer, and mental health conditions. The International Agency for Research on Cancer (IARC) classifies “night-shift work involving circadian disruption” as “probably carcinogenic to humans” (Group 2A). Advances in chronobiology now enable precise estimation of internal circadian phase using transcriptomic, metabolomic, and wearable-based assessments. This protocol outlines a 24-month prospective cohort study evaluating the association between circadian misalignment and adverse health outcomes among 500 night-shift workers and 250 day-shift controls. Circadian phase will be assessed using multi-modal biomarkers and machine-learning models. Outcomes include metabolic, cardiovascular, inflammatory, and mental-health indicators. Mixed-effects regression models will examine longitudinal associations while adjusting for lifestyle and occupational covariates. The study aims to determine the feasibility of body-clock testing for personalized health interventions and improved shift-schedule design. Findings may inform occupational health policies and contribute to circadian-based preventive strategies for shift-dependent sectors.

INTRODUCTION

The hidden backbone of a 24-hour economy

Modern economies depend on a workforce that operates around the clock. Healthcare professionals, emergency responders, transportation operators, manufacturing personnel, security staff, and countless others ensure essential services continue when most of the population sleeps. This invisible infrastructure is vital for public safety, economic stability, and national security. Globally, between 15% and 30% of the workforce engages in shift work, with a significant proportion working night shifts [1]. In countries with advanced industrialization, these numbers can be even higher due to increasing demand for uninterrupted service provision and the rise of globalized business operations [2].

The cost of working against the clock

While the economic value of shift work is unquestionable, its cost to human health is profound. Epidemiological studies consistently reveal that night-shift workers experience higher rates of cardiovascular diseases (including hypertension, coronary artery disease, and stroke); metabolic disorders (particularly obesity, insulin resistance, and type 2 diabetes); mental health conditions (notably depression, anxiety, and burnout); and cancer (particularly breast and prostate cancer, with evidence supporting the role of circadian disruption in tumor progression) [3].

These risks stem from a mismatch between the body’s endogenous circadian rhythms and externally imposed work schedules. The resulting chronic misalignment leads to physiological stress, impaired metabolic regulation, immune dysregulation, and hormonal imbalance. In 2007, the International Agency for Research on Cancer (IARC) classified “shift work involving circadian disruption” as a probable human carcinogen (Group 2A) [4,5]. This classification underscores the seriousness of the health risks and the urgent need for preventive measures.

Circadian rhythms: nature’s timekeeper

The human circadian system is orchestrated by the suprachiasmatic nucleus (SCN) in the hypothalamus. The SCN receives light input from the retina, enabling synchronization of internal time with the external environment. Through neural and hormonal pathways, the SCN coordinates peripheral clocks in nearly every tissue, regulating daily patterns of sleep–wake cycles, core body temperature, hormone release (melatonin, cortisol), blood pressure, digestion, and cellular repair mechanisms [6-12]. In shift workers, light exposure at night and sleep during daylight hours disrupt these signals. Even if a worker adapts partially to a nocturnal schedule, social and environmental factors often prevent complete alignment, leading to a constant state of “social jet lag.”

Current limitations in managing shiftwork health

Traditional occupational health strategies like slow shift rotation, controlled lighting, or sleep hygiene education offer limited benefits because they overlook individual circadian variability. Workers differ in chronotype, light sensitivity, and adaptability, meaning a “one-size-fits-all” approach often fails. Similarly, medical interventions are frequently mistimed since they follow average circadian patterns; the effectiveness of drugs, vaccines, or even surgeries can vary with biological timing [13]. For shift workers whose internal clocks are delayed or advanced, such standard schedules may prove ineffective or even detrimental.

The promise of body clock testing

Advances in body clock testing, using transcriptomic, proteomic, and metabolomic profiling of blood, saliva, or other tissues, now enable precise estimation of circadian phase. In occupational settings, these tools can support personalized drug dosing, guide shift allocation, detect early disease risk, and optimize the timing of medical interventions to improve outcomes [14-16]. This paper reviews the science of circadian biology, assesses emerging testing technologies, and proposes strategies for their integration into occupational health to reduce the burden of shift work [17]. Supplementary Material 1 describes hypothetical circadian misalignment patterns expected among day-shift, night-shift, and rotating-shift workers.

LITERATURE REVIEW

Foundations of circadian biology

Circadian rhythms are endogenously generated cycles of approximately 24 hours, modulated by environmental cues known as zeitgebers (time givers). The most potent zeitgeber is light, but others include food intake, physical activity, and temperature. The molecular mechanism of circadian rhythms involves a transcription–translation feedback loop in which core clock genes (CLOCK, BMAL1, PER, CRY) regulate their own expression through protein feedback. These rhythms are not limited to the brain; peripheral clocks exist in the liver, pancreas, heart, and other organs, enabling tissue-specific timing of metabolic and physiological functions [18,19].

Health consequences of circadian disruption

When internal and external time are misaligned, as in shiftwork, the body’s systems become desynchronized. This misalignment has been linked to:

• Metabolic dysregulation: Animal studies show that eating during the biological night promotes weight gain and insulin resistance. Human studies confirm higher rates of metabolic syndrome among night-shift workers [20].

• Cardiovascular strain: Blood pressure and heart rate normally dip during sleep; night work reduces this “nocturnal dipping,” increasing strain on the cardiovascular system [21].

• Immune dysfunction: Immune cell trafficking and cytokine release follow circadian patterns; disruption impairs immune defense and may promote chronic inflammation [22].

• Cancer risk: Light at night suppresses melatonin, a hormone with anti-cancer properties. Circadian disruption also affects DNA repair mechanisms and cell cycle regulation [23].

Supplementary Tables 1-3 summarize predicted misalignment patterns and expected health differences. Table 1 summarizes the major health risks associated with circadian misalignment across key physiological domains.

Major health risks associated with circadian misalignment across key physiological domains

Chronotherapy and time-dependent medicine

The field of chronomedicine aims to optimize the timing of medical interventions based on biological rhythms. Examples include the following:

• Antihypertensive drugs lowering blood pressure more effectively when taken at bedtime for certain patients.

• Chemotherapy shows improved tolerability and efficacy when scheduled to coincide with tumor cell susceptibility phases.

• Vaccinations produce stronger antibody responses in the morning versus the afternoon in some populations.

However, most chronotherapy research assumes a “standard” circadian phase, which may not apply to shift workers with altered internal time [24].

Current methods for measuring circadian phase

The gold standard for assessing circadian phase is dim-light melatonin onset (DLMO), measured from saliva or plasma samples collected under controlled lighting [25]. Other methods include: 1) actigraphy—wearable devices estimating sleep–wake patterns; 2) core body temperature profiling—continuous monitoring reveals circadian temperature minimum; and 3) cortisol rhythm analysis—using saliva or blood samples to detect peak and trough times. These methods, while useful, can be labor-intensive, intrusive, or insufficiently precise for clinical application (Table 2).

Comparison of conventional and emerging techniques for circadian phase assessment

Emerging body clock testing technologies

Recent research has focused on high-throughput molecular assays, including the following: 1) transcriptomic signatures—measuring the expression of circadian-regulated genes from a single blood draw can estimate internal time to within 1–2 hours [26]; 2) metabolomic profiles—circadian variations in metabolites such as amino acids and lipids offer phase markers [4]; and 3) machine learning models—integrating wearable data (activity, light exposure, heart rate) with biomarker measurements for continuous circadian phase estimation [27]. Such tools are becoming cheaper and faster, enabling their potential integration into workplace health programs (Table 2).

METHODOLOGY PROPOSAL

Study design

To investigate the potential of body clock testing in mitigating shiftwork-related health risks, a prospective cohort study is proposed. The study will enroll 500 participants engaged in rotating or permanent night shifts across diverse industries such as healthcare, transportation, and manufacturing. A control group of 250 day-shift workers will also be recruited for comparative analysis. Participants will be monitored over a 24-month period to evaluate the relationship between circadian misalignment, measured via advanced body clock testing, and various health outcomes [28,29].

Recruitment and inclusion criteria

Eligible participants will be individuals who 1) are between 20 and 60 years of age; 2) have at least 6 months of continuous shiftwork history; 3) are not on long-term nightshift leave or extended sick leave at the time of recruitment; and 4) are willing to provide informed consent for biological sample collection and data monitoring.

Methods and analysis details

The primary endpoint is the degree of circadian misalignment, defined as the difference (in hours) between internal circadian phase (estimated by transcriptomic, metabolomic, and wearable-based assessments) and scheduled work time. We will also examine the association between circadian misalignment and metabolic outcomes (HbA1c, fasting glucose, lipid profile). The secondary endpoints encompass cardiovascular outcomes, mental health, and inflammatory outcomes. Cardiovascular outcomes include blood pressure (24-h profile), resting heart rate, and arterial stiffness (pulse wave velocity). Mental health will be assessed using validated questionnaires (Patient Health Questionnaire-9 [PHQ-9] for depression, Generalized Anxiety Disorder-7 [GAD-7] for anxiety, and Pittsburgh Sleep Quality Index [PSQI] for sleep quality). Inflammatory status will be evaluated through biomarkers such as high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6). Exploratory analyses will assess the feasibility of personalized scheduling recommendations based on circadian phase.

Sample size justification

Based on prior studies, a mean HbA1c difference of 0.4% between shift and day workers is clinically significant, with assumptions of a standard deviation (SD) of 1.2%, a two-sided α of 0.05, and 80% power. Under these assumptions, the required sample size is 430 shift workers and 215 controls. With 15% expected attention over 24 months, we plan to recruit 500 shift workers and 250 controls. This sample also provides >80% power to detect a 5 mm Hg difference in systolic BP (SD 12 mm Hg), 0.5 increase in PHQ-9 score (SD 1.5), and 0.3 mg/L difference in hs-CRP (SD 0.8).

Statistical analysis plan

The primary analysis will use mixed-effects regression models to evaluate the association between circadian misalignment and outcomes over time, with random interceptions for individuals. Covariates will include age, sex, BMI, smoking status, chronotype (morning/evening preference), industry type, and years of shiftwork. Adjusted models will account for socioeconomic status, baseline health status, and comorbidities. Subgroup analyses will compare permanent night, rotating shift, and day workers; as well as industry-specific effects across healthcare, manufacturing, and transportation. Sensitivity analyses will exclude participants with <70% follow-up data; and will explore alternative misalignment definitions (e.g., actigraphy-only vs. multimodal). The primary endpoint will be tested at α=0.05, while secondary outcomes will be interpreted with false discovery rate (FDR) correction for multiplicity. Missing data will be handled using multiple imputations by chained equations (MICE), assuming data are missing at random.

Quality assurance and monitoring

Quality assurance and monitoring procedures include 1) data monitoring: quarterly audits of data completeness and accuracy by an independent quality-monitoring committee; 2) wearable compliance: automated alerts will be sent if data gaps >12 h are detected; 3) bio sample handling: standard operating procedures for blood collection, RNA sequencing, metabolomics, and cold chain transport; and 4) adverse event reporting: minor risks include phlebotomy-related bruising or discomfort. All adverse events will be logged and reported to the IRB.

Data security and privacy

All data will be stored on encrypted institutional servers (AES-256). Participant IDs will be anonymized, and analysis datasets will contain no personally identifiable information. Access will be restricted to study investigators, and external data sharing will occur only after de-identification and ethical approval.

The overall study timeline, core design parameters, and the conceptual framework underlying comparisons across worker groups are summarized in Tables 3-5. Illustrative hypothetical results, predicted outcomes, and a case vignette derived from prior literature, rather than actual study data, are presented in the Supplementary Materials 1-5.

SPIRIT schedule outlining participant enrolment, interventions, and assessments over the 24-month study period

Key design parameters of the proposed 24-month prospective cohort study

Conceptual illustration of expected differences across worker groups

DISCUSSION

Interpretation of predicted findings

If confirmed, these results would demonstrate that circadian misalignment is not only measurable at the individual level but also modifiable through tailored interventions. Personalized body clock testing could transform shiftwork health management from reactive treatment to proactive prevention [29]. The literature indicates that circadian misalignment is both measurable and modifiable. If our results align with predictions in Supplementary Materials 2 and 3, body-clock testing could be incorporated into occupational health programs to personalize interventions.

Implications for chronotherapy

The application of precise circadian phase data to medical decision-making could significantly enhance drug efficacy and safety for shift workers. For example, chemotherapy could be administered when healthy tissue is most resilient, but tumor cells are most vulnerable. Similarly, statin therapy could be timed to coincide with peak cholesterol synthesis, and influenza vaccination could be scheduled to maximize antibody response. These interventions require accurate knowledge of everyone’s body time, which current generalized guidelines cannot provide [28,29].

Workplace integration strategies

To maximize benefit, body clock testing must be integrated into broader occupational health strategies [29]. Periodic testing should be conducted annually or semi-annually for all long-term shift workers. Adaptive scheduling algorithms may assign shifts based on compatibility with workers’ chronotypes and measured internal phases. Health monitoring should allow early intervention for workers showing signs of metabolic or cardiovascular strain. Finally, education and training for both workers and managers on circadian principles, light management, and sleep hygiene are essential to support these strategies.

Addressing challenges

Several barriers must be addressed before widespread implementation. Cost is an important consideration; while molecular testing prices are decreasing, initial adoption may be expensive. Employer subsidies or insurance coverage could be explored. Privacy is also critical, as circadian data is sensitive to health information, requiring robust safeguards and voluntary participation. Equity must be ensured to prevent the creation of a two-tier workforce where there is only some benefit from schedule adjustments. Finally, there is a potential risk of misuse: as with fitness trackers, there is a risk of the technology being used for non-clinical “optimization” by healthy individuals, diverting resources from those most in need [29].

Long-term vision

In the future, wearable sensors could provide continuous circadian phase estimation without invasive sampling, allowing real-time schedule adjustments. Integration with smart lighting, meal timing, and medication dispensers could create a closed-loop circadian health system for shift workers.

RECOMMENDATIONS

For employers, pilot programs should be implemented to test feasibility of circadian phase assessments in high-risk departments. Shift rosters should be designed to minimize abrupt changes and align with workers’ chronotypes, and employees should be provided access to appropriately timed meal and rest breaks. Healthcare providers are encouraged to incorporate circadian phase testing into occupational health checkups for shift workers. adjust medication timing to match individual body clocks; and educate patients on light exposure strategies to mitigate circadian disruption. For policymakers, circadian misalignment should be recognized as an occupational health hazard, and incentives should be provided for companies to adopt science-based scheduling practices. Additionally, funding should be allocated to support longitudinal studies on the long-term health effects of circadian-based interventions.

CONCLUSION

The “graveyard shift” is not merely a colloquialism; it reflects the serious health risks posed by working against the body’s natural rhythms. With the emergence of precise body clock testing technologies, we have an unprecedented opportunity to transform how we manage the health of shift workers. By aligning medical care, work schedules, and preventive measures with individual circadian profiles, it is possible to significantly reduce the burden of cardiovascular disease, metabolic disorders, cancer, and mental health issues in this essential workforce. Realizing this vision will require collaboration between scientists, employers, healthcare providers, and policymakers. If implemented ethically and equitably, chronomedicine for shift workers could not only save lives but also improve productivity and job satisfaction, offering a new lease of life for those who keep our 24-hour world running.

Supplementary Materials

The Supplement is available with this article at https://doi.org/10.33069/cim.2025.0051.

Supplementary Material 1.

Hypothetical Patterns of Circadian Misalignment

cim-2025-0051-Supplementary-Material-1.pdf
Supplementary Material 2.

Hypothetical Associations Between Circadian Misalignment and Health Outcomes

cim-2025-0051-Supplementary-Material-2.pdf
Supplementary Material 3.

Simulation of Personalized Scheduling Benefits

cim-2025-0051-Supplementary-Material-3.pdf
Supplementary Material 4.

Hypothetical Case Vignette

cim-2025-0051-Supplementary-Material-4.pdf
Supplementary Material 5.

Interpretation of Predicted Outcomes

cim-2025-0051-Supplementary-Material-5.pdf

Notes

Ethics Statement

The study protocol was reviewed and approved by the Institutional Ethics Committee, Amity University, Lucknow (Approval No.: AUL/IEC/2025/037; Date: 10 October 2025).

The authors have no potential conflicts of interest to disclose.

Availability of Data and Material

Data generated in this study will be available upon reasonable request, following institutional ethics approval.

Author Contributions

Conceptualization: Devesh Ojha. Data curation: Devesh Ojha. Formal analysis: Devesh Ojha. Investigation: Devesh Ojha, Laxmi Ojha. Methodology: Devesh Ojha, Laxmi Ojha. Project administration: Devesh Ojha. Resources: Laxmi Ojha. Software: Devesh Ojha. Supervision: Laxmi Ojha. Validation: Devesh Ojha, Laxmi Ojha. Visualization: Devesh Ojha. Writing—original draft: Devesh Ojha. Writing—review & editing: Laxmi Ojha.

Funding Statement

None

Acknowledgments

The authors thank Amity University, Lucknow, and the Military Nursing Service for institutional support.

The study has been submitted to the Clinical Trials Registry–India (CTRI) and is currently under review (Reference No.: REF/2025/10/019789).

References

1. Ward EM, Germolec D, Kogevinas M, McCormick D, Vermeulen R, Anisimov VN, et al. Carcinogenicity of night shift work. Lancet Oncol 2019;20:1058–1059.
2. Wang XS, Armstrong ME, Cairns BJ, Key TJ, Travis RC. Shift work and chronic disease: the epidemiological evidence. Occup Med (Lond) 2011;61:78–89.
3. Zhou L, Zhang Z, Nice E, Huang C, Zhang W, Tang Y. Circadian rhythms and cancers: the intrinsic links and therapeutic potentials. J Hematol Oncol 2022;15:21.
4. Lee Y. Roles of circadian clocks in cancer pathogenesis and treatment. Exp Mol Med 2021;53:1529–1538.
5. Erren TC, Falaturi P, Morfeld P, Knauth P, Reiter RJ, Piekarski C. Shift work and cancer: the evidence and the challenge. Dtsch Arztebl Int 2010;107:657–662.
6. Wu QJ, Sun H, Wen ZY, Zhang M, Wang HY, He XH, et al. Shift work and health outcomes: an umbrella review of systematic reviews and meta-analyses of epidemiological studies. J Clin Sleep Med 2022;18:653–662.
7. Lu J, Xiao Q, Bauer C. A Bayesian circadian hidden Markov model to infer rest-activity rhythms using 24-hour actigraphy data. arXiv:2307.03832 [Internet]. arXiv; 2023 Jul 7. Available at: https://arxiv.org/abs/2307.03832. Accessed June 12, 2025.
8. Stevens RG, Hansen J, Costa G, Haus E, Kauppinen T, Aronson KJ, et al. Considerations of circadian impact for defining ‘shift work’ in cancer studies: IARC Working Group Report. Occup Environ Med 2011;68:154–162.
9. Blask DE. Melatonin, sleep disturbance and cancer risk. Sleep Med Rev 2009;13:257–264.
10. Erren TC, Morfeld P, Groß JV, Wild U, Lewis P. IARC 2019: “Night shift work” is probably carcinogenic: what about disturbed chronobiology in all walks of life? J Occup Med Toxicol 2019;14:29.
11. Skogstad M, Alsaedi S, Sirnes PA, Mamen A, Skare Ø, Goffeng E, et al. Rotating shift work, with night shift work, affects cardiovascular risk factors: a 6-year follow-up study in the insulation industry. Occup Environ Med 2025;82:326–334.
12. Li N, Wang R, Hu P, Lu W, Zhao X, Wang L, et al. Effect of night shift work on metabolic syndrome in adults who suffered from earthquake stress in early life. Front Public Health 2023;11:1139113.
13. Dong C, Zeng H, Yang B, Zhang Y, Li Z. The association between long-term night shift work and metabolic syndrome: a cross-sectional study of male railway workers in southwest China. BMC Cardiovasc Disord 2022;22:263.
14. Boivin DB, Boudreau P, Kosmadopoulos A. Disturbance of the circadian system in shift work and its health impact. J Biol Rhythms 2022;37:3–28.
15. Hemmer A, Mareschal J, Dibner C, Pralong JA, Dorribo V, Perrig S, et al. The effects of shift work on cardio-metabolic diseases and eating patterns. Nutrients 2021;13:4178.
16. He C, Wang X, Wen Y, Liu S, Fang Z, Wu H, et al. Sleep monitoring and sleep-aid intervention methods: a review. IEEE Internet Things J 2025;12:32780–32795.
17. Shi H, Huang T, Schernhammer ES, Sun Q, Wang M. Rotating night shift work and healthy aging after 24 years of follow-up in the Nurses’ Health Study. JAMA Netw Open 2022;5e2210450.
18. Lozano-Lorca M, Olmedo-Requena R, Vega-Galindo MV, Vázquez-Alonso F, Jiménez-Pacheco A, Salcedo-Bellido I, et al. Night shift work, chronotype, sleep duration, and prostate cancer risk: CAPLIFE study. Int J Environ Res Public Health 2020;17:6300.
19. Xi J, Ma W, Tao Y, Zhang X, Liu L, Wang H. Association between night shift work and cardiovascular disease: a systematic review and dose-response meta-analysis. Front Public Health 2025;13:1668848.
20. Vetter C, Devore EE, Wegrzyn LR, Massa J, Speizer FE, Kawachi I, et al. Association between rotating night shift work and risk of coronary heart disease among women. JAMA 2016;315:1726–1734.
21. Wang F, Zhang L, Zhang Y, Zhang B, He Y, Xie S, et al. Meta-analysis on night shift work and risk of metabolic syndrome. Obes Rev 2014;15:709–720.
22. Zimberg IZ, Fernandes Junior SA, Crispim CA, Tufik S, de Mello MT. Metabolic impact of shift work. Work 2012;41 Suppl 1:4376–4383.
23. Shan Z, Li Y, Zong G, Guo Y, Li J, Manson JE, et al. Rotating night shift work and adherence to unhealthy lifestyle in predicting risk of type 2 diabetes: results from two large US cohorts of female nurses. BMJ 2018;363:k4641.
24. Kecklund G, Axelsson J. Health consequences of shift work and insufficient sleep. BMJ 2016;355:i5210.
25. Wang X, Ji A, Zhu Y, Liang Z, Wu J, Li S, et al. A meta-analysis including dose-response relationship between night shift work and the risk of colorectal cancer. Oncotarget 2015;6:25046–25060.
26. Stevens RG. Circadian disruption and breast cancer. In: Bartsch C, Bartsch H, Blask DE, Cardinali DP, Hrushesky WJM, Mecke D, editors. The pineal gland and cancer: neuroimmunoendocrine mechanisms in malignancy. 1st ed. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001, p. 511-517.
27. Haus EL, Smolensky MH. Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation. Sleep Med Rev 2013;17:273–284.
28. Fritschi L, Glass DC, Heyworth JS, Aronson K, Girschik J, Boyle T, et al. Hypotheses for mechanisms linking shiftwork and cancer. Med Hypotheses 2011;77:430–436.
29. Haus E, Smolensky M. Biological clocks and shift work: circadian dysregulation and potential long-term effects. Cancer Causes Control 2006;17:489–500.

Article information Continued

Table 1.

Major health risks associated with circadian misalignment across key physiological domains

Health domain Common issues in night shift workers Key mechanisms involved Supporting references
Cardiovascular Hypertension, coronary artery disease, stroke Loss of nocturnal BP dipping, increased sympathetic activity [11,19,20,24]
Metabolic Obesity, insulin resistance, type 2 diabetes Nighttime eating, altered glucose metabolism [12,13,21-23]
Mental health Depression, anxiety, burnout Sleep deprivation, altered neurotransmitter rhythms [6,14,24]
Cancer Breast, prostate cancer Melatonin suppression, impaired DNA repair [1,9,10,18,26,27]
Immune function Increased inflammation Disrupted cytokine release patterns [6,14,29]

BP, blood pressure; IARC, International Agency for Research on Cancer.

Table 2.

Comparison of conventional and emerging techniques for circadian phase assessment

Method Sample/tool required Accuracy Advantages Limitations
Dim-light melatonin onset Saliva/plasma ±30 min Gold standard, well-validated Labor-intensive, requires controlled lighting
Actigraphy Wearable device ±1–2 h Non-invasive, continuous data Estimates sleep, not direct circadian phase
Core body temperature Temperature sensors ±1 h Tracks physiological rhythm Influenced by illness/activity
Cortisol rhythm Saliva/blood ±1–2 h Hormonal phase marker Stress and illness can skew results
Transcriptomic profiling Blood RNA sequencing ±1 h High precision, one sample Requires lab infrastructure
Metabolomic profiling Plasma LC–MS ±1–2 h Detects multiple markers Costly, complex analysis
Machine learning models Wearable + biomarkers ±1 h Integrates multiple data streams Requires algorithm validation

LC-MS, liquid chromatography–mass spectrometry.

Table 3.

SPIRIT schedule outlining participant enrolment, interventions, and assessments over the 24-month study period

Timepoint (month)*
Baseline (0) 6 12 18 24 Continuous
Eligibility & consent
Registry entry
Demographics & medical history
Wearable monitoring (sleep, activity, light) Continuous
Work schedule logging Continuous
Metabolic panel (HbA1c, glucose, lipids)
Cardiovascular markers (BP, arterial stiffness)
Mental health (PHQ-9, GAD-7, PSQI)
Inflammatory markers (hs-CRP, IL-6)
Circadian phase testing (transcriptomic, metabolomic±DLMO)
*

baseline: eligibility, consent, demographics, registry entry; follow-up: assessments at baseline, 6, 12, 18, and 24 months; continuous data: wearables and digital work schedules; quarterly: metabolic, cardiovascular, mental health, and inflammatory assessments; annual: comprehensive circadian phase testing (transcriptomic, metabolomic, optional DLMO).

SPIRIT, Standard Protocol Items: Recommendations for Interventional Trials; BP, blood pressure; PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; PSQI, Pittsburgh Sleep Quality Index; hs-CRP, high-sensitivity C-reactive protein; IL-6, interleukin-6; DLMO, dim-light melatonin onset.

Table 4.

Key design parameters of the proposed 24-month prospective cohort study

Parameter Description
Study type Prospective cohort
Duration 24 months
Participants 500 shift workers + 250-day workers
Industries covered Healthcare, transportation, manufacturing
Key measures Circadian phase, metabolic, cardiovascular, mental health, inflammatory markers
Main tools Transcriptomics, metabolomics, wearables
Analysis Mixed-effects regression models

Table 5.

Conceptual illustration of expected differences across worker groups

Health indicator (concept) Day workers Permanent night shift Rotating shift Notes
Degree of circadian misalignment Low Moderate High Literature-supported trend
Metabolic strain Low Moderate High Directional only
Inflammatory load Low Elevated Elevated Based on prior studies
Mental-health burden Low Higher Highest Consistent with epidemiology